World Hemophilia Day 2021

This day is about bringing the global bleeding disorders community together. Our patients tell us about how they are adapting to the new challenges.

Read the story

News & Stories

Study suggests that 4F-PCC can be used as a substitute for frozen plasma for the treatment of bleeding during cardiac surgery

Results of the FARES study

30.03.2021

Press release

FDA approvals strengthen Octapharma USA pediatric

Octaplas™, fibryga® receive new product labeling

Octapharma online lectures

09.06.2021

EHA2021 Virtual Congress

European Hematology Association

03.02.2021

EAHAD 2021

European Association for Haemophilia and Allied Disorders (EAHAD)

28.11.2020

Euroanaesthesia 2020

Euroanaesthesia presents innovations in anaesthesia and other forms of critical care.

Check all our virtual events

Patient Engagement

Octapharma takes an active role in our community

We sponsor and support organisations worldwide.

Learn how we engage with patients

Careers and Jobs

Explore a new world of opportunities

Our global presence offers you a great opportunity to gain international experience. Every employee contributes to the ongoing success of the company.

Working with Octapharma

World Hemophilia Day 2021

Check out our latest stories

Patient Blood Management – A new standard of care

Committed to the fight against COVID-19

Study suggests that 4F-PCC can be used as a substitute for frozen plasma for the treatment of bleeding during cardiac surgery

FDA approvals strengthen Octapharma USA pediatric

Octapharma online lectures

EHA2021 Virtual Congress

EAHAD 2021

Euroanaesthesia 2020

Octapharma takes an active role in our community

Explore a new world of opportunities

About us

Plasma

Products

Careers

Engagement

News